After NIRF, Jamia Hamdard eyes Times World Rankings
After ranking as the best Pharmacy institute for the third consecutive year in NIRF, Jamia Hamdard is now eyeing for a global limelight.
Image used for representational purpose only The research publications by Jamia Hamdard are globally recognized and have better engagement and referrals than IITs.
After ranking as the best Pharmacy institute for the third consecutive year in NIRF, Jamia Hamdard is now eyeing for a global limelight. In the QS World University Rankings Hamdard’s School of Pharmaceutical Education and Research (SPER) figures in the top 151-200 global list and it will also participate in the Times World Rankings after a hiatus of four years.
Vice chancellor Seyed Ehtesham Hasnain credits the success to the robust research ecosystem and highly qualified faculty members in the campus. In 2019, the university produced 443 publications and 405 in 2018. He adds that the university is also one of the most diverse campuses with around 800 students enrolled from over 32 countries.
“The research publications by Jamia Hamdard are globally recognized and see better engagement and referrals than most publications by the IITs. The university has some of the best researchers and faculty members including two Fullbright scholars and experts from John Hopkins, Pennsylvania State University,” says Hasnain. “My aim is to improve the overall international ranking for Jamia Hamdard and see it placed in the top 50-100 Institutions,” he adds.
While he agrees that the parameters used for international rankings are biased against Indian institutes and some give as much as 30% weightage to perception, Hasnain believes the participation is still important to put Indian institutes on the world map.
Popularity of Pharmacy courses
While it is true that students come to this discipline by choice and rarely by default, there is still scope for making it popular among the masses. “The reason is that unlike the IT world, the discipline lacks role models even when some of the best brains in the country are doing phenomenal work. Engineering students, which is a large chunk of the Indian student population, have numerous famous personalities to look up to but it is hard to say the same for pharmacy,” says the vice chancellor, adding that in the light of COVID-19, the discipline will acquire a newer dimension.
To further improve the quality of Pharmacy institutes in India, he says, focus should be put on creating intellectual property rather than limiting India to being only the largest drug producer and supplier. “In the coming years, pharmacy will also reposition itself more strongly in the drug discovery. India is lagging in this area. India is popular as generic drug manufacturers, in fact, the largest in the world. Given our intellect, investment, and the quality of education we should see many novel drugs coming out of research done in India. This is slowly happening but will need to be fast-tracked,” says Hasnain. There is need to attract big pharma companies to join hands with academia for R&D.
After ranking as the best Pharmacy institute for the third consecutive year in NIRF, Jamia Hamdard is now eyeing for a global limelight. In the QS World University Rankings Hamdard’s School of Pharmaceutical Education and Research (SPER) figures in the top 151-200 global list and it will also participate in the Times World Rankings after a hiatus of four years.
Vice chancellor Seyed Ehtesham Hasnain credits the success to the robust research ecosystem and highly qualified faculty members in the campus. In 2019, the university produced 443 publications and 405 in 2018. He adds that the university is also one of the most diverse campuses with around 800 students enrolled from over 32 countries.
“The research publications by Jamia Hamdard are globally recognized and see better engagement and referrals than most publications by the IITs. The university has some of the best researchers and faculty members including two Fullbright scholars and experts from John Hopkins, Pennsylvania State University,” says Hasnain. “My aim is to improve the overall international ranking for Jamia Hamdard and see it placed in the top 50-100 Institutions,” he adds.
While he agrees that the parameters used for international rankings are biased against Indian institutes and some give as much as 30% weightage to perception, Hasnain believes the participation is still important to put Indian institutes on the world map.
Popularity of Pharmacy courses
While it is true that students come to this discipline by choice and rarely by default, there is still scope for making it popular among the masses. “The reason is that unlike the IT world, the discipline lacks role models even when some of the best brains in the country are doing phenomenal work. Engineering students, which is a large chunk of the Indian student population, have numerous famous personalities to look up to but it is hard to say the same for pharmacy,” says the vice chancellor, adding that in the light of COVID-19, the discipline will acquire a newer dimension.
To further improve the quality of Pharmacy institutes in India, he says, focus should be put on creating intellectual property rather than limiting India to being only the largest drug producer and supplier. “In the coming years, pharmacy will also reposition itself more strongly in the drug discovery. India is lagging in this area. India is popular as generic drug manufacturers, in fact, the largest in the world. Given our intellect, investment, and the quality of education we should see many novel drugs coming out of research done in India. This is slowly happening but will need to be fast-tracked,” says Hasnain. There is need to attract big pharma companies to join hands with academia for R&D.
All Comments ()+^ Back to Top
Refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Help us delete comments that do not follow these guidelines by marking them offensive. Let's work together to keep the conversation civil.
HIDE